Prostate Cancer

Our prostate program is an NIH-recognized and funded consortium of cohesive investigators and clinicians. We see patients at UW Medicine and the Seattle Cancer Care Alliance and offer cancer screenings, personalized treatment strategies and cutting-edge clinical trials.

One of our major strengths is identification of risk assessment in the progression of prostate cancer to highly aggressive forms. We also have a large program in studying the biology of these tumors and developing novel therapies.

Increase in PSA After Prostate Surgery May Not Lead To Cancer Metastasis

Some prostate cancer patients whose prostate-specific antigen levels increase after a radical prostatectomy may die of causes unrelated to prostate cancer.

Guidelines for Managing Patients with Prostate Cancer

NCCN Guidelines for Prostate Cancer provide multidisciplinary recommendations on the clinical management of patients. Dr. Tia Higano, UW researcher, contributed to the newest recommendations.

What is Quality Prostate Cancer Care?

STTR researcher Dr. John Gore discusses how we strive to improve outcomes

Physical Activity and Weight Management are Important Tools for Prostate Cancer Prevention

STTR researcher and clinician Dr. Jonathan Wright highlights the importance of exercise and maintaining a healthy weight in prostate cancer prevention.